Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,1.6218066290088816e-54,57.096306685367,7071.723260622375,"['RPL5', 'RPL30', 'RPL3', 'RPL32', 'RPL34', 'RPLP1', 'RPL10A', 'RPL8', 'RPL9', 'RPL6', 'RPL7', 'RPS4X', 'RPS15', 'RPL7A', 'RPS14', 'RPS16', 'RPL18A', 'RPS19', 'RPS18', 'RPL36', 'RPL35', 'RPLP2', 'RPL38', 'RPL37', 'RPL39', 'RPS10', 'RPS13', 'RPS12', 'RPS9', 'RPS7', 'RPL21', 'RPS8', 'RPL23', 'RPS5', 'RPS6', 'RPL22', 'RPL13A', 'RPSA', 'RPS3A', 'RPL37A', 'RPL24', 'RPL27', 'RPL26', 'RPL29', 'RPL28', 'UBA52', 'RPL10', 'RPL12', 'RPL11', 'RPL36A', 'RPS15A', 'RPL14', 'RPS3', 'RPL13', 'RPS2', 'RPL15', 'RPS27A', 'RPL18', 'RPL17', 'RPL19', 'RPL41', 'RPL35A', 'RPL23A', 'RPS26', 'RPS25', 'RPS28', 'RPS27', 'RPS29', 'RPL27A', 'FAU', 'RPS21', 'RPS24', 'RPS23']",5.741195466691441e-52,0,0,73
2,Electron Transport Chain (OXPHOS system in mitochondria) WP111,3.5914679844925776e-37,31.450068399452803,2639.1981390069514,"['COX7B', 'NDUFA12', 'COX4I1', 'COX6A1', 'COX7C', 'ATP5IF1', 'UQCRFS1', 'NDUFC2', 'NDUFC1', 'COX6B1', 'NDUFS8', 'NDUFS6', 'NDUFS5', 'NDUFS3', 'SLC25A5', 'SLC25A4', 'NDUFB9', 'NDUFB8', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB5', 'COX17', 'NDUFB3', 'ATP5MC2', 'NDUFB2', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'COX7A1', 'COX5A', 'UQCRH', 'ATP5MC1', 'ATP5F1A', 'ATP5F1B', 'ATP5MG', 'ATP5MF', 'ATP5ME', 'ATP5PF', 'SURF1', 'NDUFA7', 'ATP5PD', 'NDUFA6', 'NDUFA5', 'NDUFA4', 'NDUFA2', 'NDUFA1', 'COX6C', 'ATP5F1D', 'ATP5F1E', 'UQCRQ', 'NDUFAB1', 'ATP5PO']",6.356898332551862e-35,0,0,55
3,Oxidative phosphorylation WP623,8.394238365370917e-23,31.434832100170745,1597.8926057613064,"['NDUFB9', 'NDUFB8', 'NDUFB7', 'NDUFA11', 'NDUFB10', 'NDUFB5', 'ATP5MC2', 'NDUFB2', 'NDUFB1', 'ATP5MC1', 'ATP5F1A', 'ATP5F1B', 'ATP5MG', 'ATP5MF', 'ATP5ME', 'ATP5PF', 'NDUFA7', 'NDUFA6', 'ATP5PD', 'NDUFA5', 'NDUFA4', 'ATP6AP2', 'NDUFA2', 'NDUFC2', 'NDUFC1', 'ATP5F1D', 'ATP5F1E', 'NDUFS8', 'NDUFS6', 'NDUFS5', 'NDUFAB1', 'NDUFS3', 'ATP5PO']",9.905201271137682e-21,0,0,33
4,Nonalcoholic fatty liver disease WP4396,3.3316950641307748e-21,9.341638143755473,440.46576550418234,"['NDUFB9', 'NDUFA13', 'COX7B', 'NDUFB8', 'NDUFB7', 'NDUFA11', 'UQCRB', 'NDUFB10', 'NDUFA12', 'NDUFB11', 'NDUFB5', 'COX4I1', 'NDUFB3', 'NDUFB2', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX6A1', 'COX5B', 'COX7A1', 'COX7C', 'COX5A', 'UQCRH', 'UQCRFS1', 'CYC1', 'NDUFA7', 'NDUFA6', 'NDUFA5', 'NDUFA4', 'NDUFA2', 'NDUFA1', 'NDUFC2', 'NDUFC1', 'COX6C', 'EIF2S1', 'COX6B1', 'NDUFS8', 'UQCRQ', 'NDUFS6', 'DDIT3', 'NDUFS5', 'NDUFAB1', 'NDUFS3', 'CYCS', 'BAX', 'PPARA']",2.9485501317557355e-19,0,0,47
5,Mitochondrial complex I assembly model OXPHOS system WP4324,1.8615519101870045e-13,15.126343381389253,443.38633755329363,"['NDUFB9', 'NDUFA13', 'NDUFB8', 'NDUFA7', 'NDUFB7', 'NDUFA6', 'DMAC1', 'NDUFB10', 'NDUFA5', 'NDUFA12', 'NDUFB11', 'NDUFB5', 'NDUFB3', 'NDUFA2', 'NDUFB2', 'NDUFA1', 'NDUFC2', 'NDUFB1', 'NDUFC1', 'NDUFS6', 'NDUFS5', 'NDUFAB1', 'NDUFS3']",1.317978752412399e-11,0,0,23
6,Mitochondrial CIV Assembly WP4922,6.706062246965893e-09,11.587878787878788,218.08682102754804,"['COA3', 'COX7B', 'SURF1', 'PET100', 'NDUFA4', 'COX4I1', 'COX17', 'COX7A2', 'COX6A1', 'COX5B', 'COX6C', 'COX5A', 'COX7C', 'COX6B1', 'COX14', 'COX20']",3.9565767257098767e-07,0,0,16
7,Mitochondrial complex III assembly WP4921,3.2282718981480547e-05,12.915167095115681,133.55546508609854,"['UQCRB', 'UQCC3', 'UQCRQ', 'UQCRFS1', 'UQCR11', 'UQCR10', 'CYC1', 'UQCRH']",0.0016325832170634446,0,0,8
8,Cellular Proteostasis WP4918,0.003965549177369511,12.854219948849105,71.08526219994485,"['VBP1', 'PFDN4', 'PFDN5', 'PFDN6']",0.15597826764320077,0,0,4
9,Glycolysis in senescence WP5049,0.003965549177369511,12.854219948849105,71.08526219994485,"['LDHA', 'PKM', 'ALDOC', 'GAPDH']",0.15597826764320077,0,0,4
10,Synaptic Vesicle Pathway WP2267,0.00810911786556277,3.436503856041131,16.545962570900436,"['SLC32A1', 'CLTC', 'AP2S1', 'PARK7', 'SYP', 'SLC25A4', 'AP2M1', 'CPLX3']",0.26122563995878273,0,0,8
11,nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell WP5027,0.00826652016112896,8.567774936061381,41.08712144301649,"['EIF3I', 'EIF2S1', 'EIF3D', 'EIF1']",0.26122563995878273,0,0,4
12,Glutathione metabolism WP100,0.008855106439280771,19.260536398467433,91.03995204801156,"['GPX4', 'IDH1', 'GSS']",0.26122563995878273,0,0,3
13,Proteasome Degradation WP183,0.011560804026252161,2.9003861003861005,12.93611317036027,"['PSMB6', 'PSMC5', 'PSMB5', 'UBB', 'H2AFZ', 'PSMC1', 'HLA-B', 'UBA1', 'PSMB10']",0.29759158934108365,0,0,9
14,Pyrimidine metabolism WP4022,0.011835445368436509,2.5345622119815667,11.244981672305705,"['POLE4', 'POLR3GL', 'POLD2', 'NME2', 'ENPP1', 'NME3', 'POLR2I', 'DCTPP1', 'POLR2K', 'NME1', 'POLR2L']",0.29759158934108365,0,0,11
15,Ferroptosis WP4313,0.012609813107673035,3.4664757578749876,15.159868929342085,"['MAP1LC3A', 'GPX4', 'FTH1', 'GSS', 'SLC3A2', 'SAT2', 'FTL']",0.29759158934108365,0,0,7
16,Translation Factors WP107,0.017874047594939005,2.86203941730934,11.518007095601345,"['EEF1B2', 'EIF2B5', 'EIF2AK1', 'EIF3I', 'EIF2B1', 'EIF2S1', 'EIF3D', 'EIF1']",0.37815545763602953,0,0,8
17,Amino Acid metabolism WP3925,0.018160007852577688,2.6356616356616356,10.56513789110169,"['LDHA', 'PKM', 'GOT1', 'MDH2', 'RARS', 'IDH1', 'GSS', 'ODC1', 'SRM']",0.37815545763602953,0,0,9
18,Glycolysis and Gluconeogenesis WP534,0.021789602922472007,3.0030808729139924,11.490755472246796,"['LDHA', 'PKM', 'GOT1', 'MDH2', 'PGAM1', 'ALDOC', 'GAPDH']",0.4285288574752828,0,0,7
19,7q11.23 copy number variation syndrome WP4932,0.02301279959707272,2.149870801033592,8.108677833939891,"['ATP5F1A', 'ATP5F1B', 'CLTC', 'ATP5MC2', 'ATP5PO', 'SQSTM1', 'GAPDH', 'ATP5F1D', 'VPS28', 'CLASP1', 'ATP5F1E', 'ATP5MC1']",0.4287647924928286,0,0,12
20,Base Excision Repair WP4752,0.02631610201268457,3.2153846153846155,11.696200387889439,"['POLE4', 'NEIL2', 'MPG', 'TDG', 'APEX1', 'POLD2']",0.46579500562451687,0,0,6
21,Cytosine methylation WP3585,0.049843810788849835,12.823979591836734,38.457331582769385,"['IDH1', 'TDG']",0.8344120047349564,0,0,2
22,Urea cycle and metabolism of amino groups WP497,0.056570305405759753,4.812260536398467,13.822116724420791,"['ODC1', 'CKB', 'SRM']",0.8344120047349564,0,0,3
23,Cori Cycle WP1946,0.056570305405759753,4.812260536398467,13.822116724420791,"['LDHA', 'PGAM1', 'GAPDH']",0.8344120047349564,0,0,3
24,Nanomaterial induced apoptosis WP2507,0.056570305405759753,4.812260536398467,13.822116724420791,"['ENDOG', 'BAX', 'CYCS']",0.8344120047349564,0,0,3
25,Selenium Micronutrient Network WP15,0.0662337809562953,2.4096153846153845,6.54105676688877,"['SELENOM', 'PRDX5', 'GPX4', 'SELENOW', 'SELENOK', 'SELENOH']",0.9378703383411414,0,0,6
26,Metabolic reprogramming in colon cancer WP4290,0.07980754010558552,2.267420814479638,5.7323511164990215,"['LDHA', 'PKM', 'MDH2', 'PGAM1', 'GAPDH', 'IDH3A']",0.9999321719694557,0,0,6
27,Computational Model of Aerobic Glycolysis WP4629,0.08164472548887836,3.8490421455938697,9.643305746227481,"['LDHA', 'PKM', 'GAPDH']",0.9999321719694557,0,0,3
28,Nucleotide metabolism WP404,0.08164472548887836,3.8490421455938697,9.643305746227481,"['NME2', 'OAZ1', 'SRM']",0.9999321719694557,0,0,3
29,Arachidonate Epoxygenase / Epoxide Hydrolase WP678,0.09083257065964565,6.410714285714286,15.37761979725584,"['GSTP1', 'COX5A']",0.9999321719694557,0,0,2
30,Dual hijack model of Vif in HIV infection WP3300,0.09083257065964565,6.410714285714286,15.37761979725584,"['UBB', 'ELOB']",0.9999321719694557,0,0,2
31,CAMKK2  Pathway WP4874,0.10936951192273849,2.566751918158568,5.680281318347349,"['FIS1', 'MAP1LC3A', 'SQSTM1', 'CALM2']",0.9999321719694557,0,0,4
32,Gastric Cancer Network 2 WP2363,0.11056856774725769,3.206896551724138,7.061969199718642,"['OTUD5', 'S100A6', 'BRIX1']",0.9999321719694557,0,0,3
33,DNA Repair Pathways Full Network WP4946,0.11754994164105528,1.7013399954576425,3.6423851863324614,"['POLE4', 'DCLRE1C', 'NEIL2', 'CENPX', 'MPG', 'TDG', 'APEX1', 'POLD2', 'GTF2H5']",0.9999321719694557,0,0,9
34,Parkinson's disease pathway WP2371,0.1339612264039135,2.3329458265519647,4.689699076205356,"['UBB', 'CYCS', 'UBA1', 'PARK7']",0.9999321719694557,0,0,4
35,EV release from cardiac cells and their functional effects WP3297,0.135190660343852,inf,inf,['RGS16'],0.9999321719694557,0,0,1
36,Nanomaterial-induced inflammasome activation WP3890,0.135190660343852,inf,inf,['CTSB'],0.9999321719694557,0,0,1
37,Nanoparticle triggered regulated necrosis WP2513,0.135190660343852,inf,inf,['FTL'],0.9999321719694557,0,0,1
38,Wnt signaling in kidney disease WP4150,0.13810959332721848,4.2729591836734695,8.459210430382683,"['WNT2B', 'DVL3']",0.9999321719694557,0,0,2
39,Cysteine and methionine catabolism WP4504,0.13810959332721848,4.2729591836734695,8.459210430382683,"['GOT1', 'GSS']",0.9999321719694557,0,0,2
40,Host-pathogen interaction of human coronaviruses - autophagy WP4863,0.13810959332721848,4.2729591836734695,8.459210430382683,"['MAP1LC3A', 'WIPI1']",0.9999321719694557,0,0,2
41,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.14274034703096952,2.7482211275314725,5.350039168198045,"['H3F3B', 'BCL6', 'H2AFZ']",0.9999321719694557,0,0,3
42,mRNA Processing WP411,0.1521633687626008,1.5042141386410433,2.832135193747164,"['LSM7', 'SF3A1', 'CELF1', 'SNRPG', 'SNRPB2', 'SNRPF', 'DNAJC8', 'HNRNPA1', 'SRSF7', 'PRPF8', 'SRSF9']",0.9999321719694557,0,0,11
43,GABA receptor Signaling WP4159,0.16055560880096947,2.1381074168797953,3.910844185628281,"['GABBR1', 'SLC32A1', 'AP2S1', 'AP2M1']",0.9999321719694557,0,0,4
44,TCA Cycle (aka Krebs or citric acid cycle) WP78,0.17752983301883948,2.4042145593869733,4.155965223388912,"['MDH2', 'IDH3G', 'IDH3A']",0.9999321719694557,0,0,3
45,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.17752983301883948,2.4042145593869733,4.155965223388912,"['NDUFA13', 'HSP90AA1', 'AAMP']",0.9999321719694557,0,0,3
46,SARS-CoV-2 mitochondrial interactions WP5038,0.17752983301883948,2.4042145593869733,4.155965223388912,"['TOMM70', 'NDUFB9', 'IRF3']",0.9999321719694557,0,0,3
47,HIF1A and PPARG regulation of glycolysis WP2456,0.1892300769488657,3.204081632653061,5.334128398981814,"['LDHA', 'GAPDH']",0.9999321719694557,0,0,2
48,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.1910906940262188,1.7819035424669227,2.9490630602740677,"['PPP1R3F', 'MAP1LC3A', 'EIF2AK1', 'DDIT3', 'EIF2S1']",0.9999321719694557,0,0,5
49,Cytosolic DNA-sensing pathway WP4655,0.21861893026622933,1.8319327731092436,2.785316586689344,"['IRF3', 'POLR3GL', 'POLR2K', 'POLR2L']",0.9999321719694557,0,0,4
50,Modulators of TCR signaling and T cell activation WP5072,0.21861893026622933,1.8319327731092436,2.785316586689344,"['FIBP', 'NDUFB10', 'ELOB', 'RNF7']",0.9999321719694557,0,0,4
51,Alzheimer's disease WP2059,0.23469848262446488,1.5393846153846154,2.231266636156044,"['ATP5MD', 'APH1A', 'CHP1', 'CYCS', 'GAPDH', 'CALM2']",0.9999321719694557,0,0,6
52,NRF2 pathway WP2884,0.23726232220670265,1.4258783204798628,2.0512527319990075,"['HSP90AA1', 'FTH1', 'GSTP1', 'BLVRB', 'SLC39A7', 'SQSTM1', 'CES2', 'FTL']",0.9999321719694557,0,0,8
53,Zinc homeostasis WP3529,0.24229399290211046,2.5627551020408164,3.6329704573763966,"['SLC30A3', 'SLC39A7']",0.9999321719694557,0,0,2
54,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.24229399290211046,2.5627551020408164,3.6329704573763966,"['FGF1', 'GTPBP4']",0.9999321719694557,0,0,2
55,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.24229399290211046,2.5627551020408164,3.6329704573763966,"['GOT1', 'MDH2']",0.9999321719694557,0,0,2
56,Regulation of Microtubule Cytoskeleton WP2038,0.24949853676089295,1.709462915601023,2.373251175256,"['PARD6A', 'STMN1', 'MAPRE1', 'CLASP1']",0.9999321719694557,0,0,4
57,Control of immune tolerance by vasoactive intestinal peptide WP4484,0.25212499012646933,6.4038216560509555,8.82337965354845,['VIP'],0.9999321719694557,0,0,1
58,"Gamma-glutamyl cycle for the biosynthesis and degradation of glutathione, including diseases WP4518",0.25212499012646933,6.4038216560509555,8.82337965354845,['GSS'],0.9999321719694557,0,0,1
59,Gastric acid production WP2596,0.25212499012646933,6.4038216560509555,8.82337965354845,['VIP'],0.9999321719694557,0,0,1
60,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.25212499012646933,6.4038216560509555,8.82337965354845,['ELOB'],0.9999321719694557,0,0,1
61,IL-10 Anti-inflammatory Signaling Pathway  WP4495,0.25212499012646933,6.4038216560509555,8.82337965354845,['BLVRB'],0.9999321719694557,0,0,1
62,Irinotecan pathway WP229,0.25212499012646933,6.4038216560509555,8.82337965354845,['CES2'],0.9999321719694557,0,0,1
63,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.25212499012646933,6.4038216560509555,8.82337965354845,['BAX'],0.9999321719694557,0,0,1
64,Peroxiredoxin 2 induced ovarian failure WP4873,0.25212499012646933,6.4038216560509555,8.82337965354845,['BAX'],0.9999321719694557,0,0,1
65,"Phase I biotransformations, non P450 WP136",0.25212499012646933,6.4038216560509555,8.82337965354845,['CES2'],0.9999321719694557,0,0,1
66,Differentiation Pathway WP2848,0.25249603549309635,1.9226053639846743,2.646196602376421,"['WNT2B', 'KIT', 'FGF1']",0.9999321719694557,0,0,3
67,IL-18 signaling pathway WP4754,0.28046491199468687,1.2452549670792223,1.58310092404512,"['TOMM40', 'USP5', 'CD81', 'RGS16', 'COX17', 'NDUFC1', 'RND2', 'NACA', 'TMSB4X', 'STMN1', 'CYCS', 'BAX', 'AARS']",0.9999321719694557,0,0,13
68,Histone Modifications WP2369,0.29153053962506187,1.7474747474747474,2.153955742364339,"['SET', 'H3F3B', 'SETDB2']",0.9999321719694557,0,0,3
69,NO/cGMP/PKG mediated Neuroprotection WP4008,0.29153053962506187,1.7474747474747474,2.153955742364339,"['PDE3A', 'CYCS', 'CALM2']",0.9999321719694557,0,0,3
70,16p11.2 distal deletion syndrome WP4950,0.29584374667035934,2.135204081632653,2.600515969035062,"['CD81', 'SPNS1']",0.9999321719694557,0,0,2
71,Type II interferon signaling (IFNG) WP619,0.29584374667035934,2.135204081632653,2.600515969035062,"['IFNGR2', 'HLA-B']",0.9999321719694557,0,0,2
72,Urea cycle and associated pathways WP4595,0.29584374667035934,2.135204081632653,2.600515969035062,"['GOT1', 'MDH2']",0.9999321719694557,0,0,2
73,DNA Mismatch Repair WP531,0.29584374667035934,2.135204081632653,2.600515969035062,"['POLE4', 'POLD2']",0.9999321719694557,0,0,2
74,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.29584374667035934,2.135204081632653,2.600515969035062,"['CD63', 'CD81']",0.9999321719694557,0,0,2
75,Hippo-Yap signaling pathway WP4537,0.29584374667035934,2.135204081632653,2.600515969035062,"['MAP4K2', 'TNIK']",0.9999321719694557,0,0,2
76,miRNA regulation of p53 pathway in prostate cancer WP3982,0.29584374667035934,2.135204081632653,2.600515969035062,"['SHISA5', 'BAX']",0.9999321719694557,0,0,2
77,Pregnane X receptor pathway WP2876,0.29584374667035934,2.135204081632653,2.600515969035062,"['HSP90AA1', 'PSMC5']",0.9999321719694557,0,0,2
78,Proximal tubule transport WP4917,0.3135019579098613,1.5077478561757183,1.7489116336453694,"['ATP6V1A', 'ATP6V1G1', 'SLC3A2', 'ATP6V1F']",0.9999321719694557,0,0,4
79,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.3309228620069587,1.6015325670498084,1.7710867815835567,"['MAP1LC3A', 'WIPI1', 'FTL']",0.9999321719694557,0,0,3
80,VEGFA-VEGFR2 Signaling Pathway WP3888,0.3332240259211578,1.122235189252272,1.2332694359133447,"['YWHAE', 'RPL5', 'SET', 'CLTC', 'RPL10A', 'RPL7', 'SCUBE2', 'LDHA', 'RPL18A', 'TMSB4X', 'AP2S1', 'RPLP2', 'CCT7', 'HSP90AA1', 'TRPC3', 'RPS6', 'SARS', 'RPL13A', 'CYCS', 'RPL27', 'RPL26', 'ATP6V0D1', 'GAPDH', 'EIF3D', 'PTMA']",0.9999321719694557,0,0,25
81,Neural Crest Cell Migration during Development WP4564,0.34877950269616814,1.8298104956268222,1.927367489734495,"['CDH11', 'EPHB3']",0.9999321719694557,0,0,2
82,Neural Crest Cell Migration in Cancer WP4565,0.34877950269616814,1.8298104956268222,1.927367489734495,"['CDH11', 'EPHB3']",0.9999321719694557,0,0,2
83,Apoptosis Modulation by HSP70 WP384,0.35326555771782897,3.2012738853503184,3.3310382160834626,['CYCS'],0.9999321719694557,0,0,1
84,Trans-sulfuration pathway WP2333,0.35326555771782897,3.2012738853503184,3.3310382160834626,['GOT1'],0.9999321719694557,0,0,1
85,Eicosanoid metabolism via cytochrome P450 monooxygenases (CYP) pathway WP4720,0.35326555771782897,3.2012738853503184,3.3310382160834626,['PPARA'],0.9999321719694557,0,0,1
86,Eicosanoid metabolism via lipooxygenases (LOX) WP4721,0.35326555771782897,3.2012738853503184,3.3310382160834626,['PPARA'],0.9999321719694557,0,0,1
87,Homologous recombination WP186,0.35326555771782897,3.2012738853503184,3.3310382160834626,['POLD2'],0.9999321719694557,0,0,1
88,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.35326555771782897,3.2012738853503184,3.3310382160834626,['VEGFB'],0.9999321719694557,0,0,1
89,Mitochondrial LC-Fatty Acid Beta-Oxidation WP368,0.35326555771782897,3.2012738853503184,3.3310382160834626,['ECI1'],0.9999321719694557,0,0,1
90,Non-homologous end joining WP438,0.35326555771782897,3.2012738853503184,3.3310382160834626,['DCLRE1C'],0.9999321719694557,0,0,1
91,Osteoclast Signaling WP12,0.35326555771782897,3.2012738853503184,3.3310382160834626,['ATP6V1G1'],0.9999321719694557,0,0,1
92,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.3702383728137894,1.4780430297671676,1.468595718576603,"['LDHA', 'PKM', 'BAX']",0.9999321719694557,0,0,3
93,Eukaryotic Transcription Initiation WP405,0.3787098683390515,1.3484991250504779,1.3093722691451888,"['TAF13', 'TAF6', 'POLR2I', 'POLR2K']",0.9999321719694557,0,0,4
94,Ciliary landscape WP4352,0.39418903210412914,1.125869724834796,1.0480999446423251,"['NDUFA5', 'SSNA1', 'VPS4A', 'COPS7A', 'MYL6B', 'COX6C', 'LSM4', 'MYL6', 'MFAP1', 'DVL3', 'SNRPB2', 'DCAF11', 'CALM2']",0.9999321719694557,0,0,13
95,TP53 network WP1742,0.40028927653895824,1.600765306122449,1.465609172690094,"['SUMO1', 'BAX']",0.9999321719694557,0,0,2
96,PKC-gamma calcium signaling pathway in ataxia WP4760,0.40028927653895824,1.600765306122449,1.465609172690094,"['PRKCG', 'TRPC3']",0.9999321719694557,0,0,2
97,Ebola Virus Pathway on Host WP4217,0.409618529365192,1.2009615384615384,1.0718929632177732,"['IRF3', 'CLTC', 'VPS4A', 'HLA-B', 'EIF2S1', 'CTSB']",0.9999321719694557,0,0,6
98,Acute viral myocarditis WP4298,0.4111665859693605,1.2808184143222507,1.1383361110866872,"['ENDOG', 'CYCS', 'BAX', 'DMD']",0.9999321719694557,0,0,4
99,Selective expression of chemokine receptors during T-cell polarization WP4494,0.4407431844363062,2.1337579617834397,1.748172794033504,['IFNGR2'],0.9999321719694557,0,0,1
100,ACE Inhibitor Pathway WP554,0.4407431844363062,2.1337579617834397,1.748172794033504,['ATP6AP2'],0.9999321719694557,0,0,1
101,Aspirin and miRNAs WP4707,0.4407431844363062,2.1337579617834397,1.748172794033504,['PPARA'],0.9999321719694557,0,0,1
102,TCA cycle in senescence WP5050,0.4407431844363062,2.1337579617834397,1.748172794033504,['GOT1'],0.9999321719694557,0,0,1
103,Biomarkers for urea cycle disorders WP4583,0.4407431844363062,2.1337579617834397,1.748172794033504,['GOT1'],0.9999321719694557,0,0,1
104,Estrogen Receptor Pathway WP2881,0.4407431844363062,2.1337579617834397,1.748172794033504,['PPARA'],0.9999321719694557,0,0,1
105,"GPCRs, Class C Metabotropic glutamate, pheromone WP501",0.4407431844363062,2.1337579617834397,1.748172794033504,['GABBR1'],0.9999321719694557,0,0,1
106,Interleukin-1 Induced Activation of NF-kappa-B WP3656,0.4407431844363062,2.1337579617834397,1.748172794033504,['SQSTM1'],0.9999321719694557,0,0,1
107,Mitochondrial fatty acid synthesis pathway WP4317,0.4407431844363062,2.1337579617834397,1.748172794033504,['HSD17B12'],0.9999321719694557,0,0,1
108,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.4471991650486269,1.2804597701149425,1.0304515675488106,"['DLG1', 'CHP1', 'CALM2']",0.9999321719694557,0,0,3
109,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.4471991650486269,1.2804597701149425,1.0304515675488106,"['OTUD5', 'IRF3', 'PIN1']",0.9999321719694557,0,0,3
110,TCA Cycle and Deficiency of Pyruvate Dehydrogenase complex (PDHc) WP2453,0.44979135550779487,1.4226190476190477,1.1366320148906952,"['IDH1', 'IDH3A']",0.9999321719694557,0,0,2
111,White fat cell differentiation WP4149,0.44979135550779487,1.4226190476190477,1.1366320148906952,"['IRF3', 'DDIT3']",0.9999321719694557,0,0,2
112,Fluoropyrimidine Activity WP1601,0.44979135550779487,1.4226190476190477,1.1366320148906952,"['TDG', 'CES2']",0.9999321719694557,0,0,2
113,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.44979135550779487,1.4226190476190477,1.1366320148906952,"['LDHA', 'RPS6']",0.9999321719694557,0,0,2
114,Methionine De Novo and Salvage Pathway WP3580,0.44979135550779487,1.4226190476190477,1.1366320148906952,"['ODC1', 'SRM']",0.9999321719694557,0,0,2
115,Allograft Rejection WP2328,0.4968869985315701,1.2801020408163266,0.8952939533191204,"['COL5A1', 'HLA-B']",0.9999321719694557,0,0,2
116,Notch Signaling WP268,0.4968869985315701,1.2801020408163266,0.8952939533191204,"['APH1A', 'DVL3']",0.9999321719694557,0,0,2
117,STING pathway in Kawasaki-like disease and COVID-19 WP4961,0.5164015396572211,1.6,1.0573930215896428,['IRF3'],0.9999321719694557,0,0,1
118,Biomarkers for pyrimidine metabolism disorders WP4584,0.5164015396572211,1.6,1.0573930215896428,['CKB'],0.9999321719694557,0,0,1
119,Transcriptional cascade regulating adipogenesis WP4211,0.5164015396572211,1.6,1.0573930215896428,['DDIT3'],0.9999321719694557,0,0,1
120,"Cerebral organic acidurias, including diseases WP4519",0.5164015396572211,1.6,1.0573930215896428,['MDH2'],0.9999321719694557,0,0,1
121,Complement and Coagulation Cascades WP558,0.5164015396572211,1.6,1.0573930215896428,['CLTC'],0.9999321719694557,0,0,1
122,Heart Development WP1591,0.5164015396572211,1.6,1.0573930215896428,['VEGFB'],0.9999321719694557,0,0,1
123,Insulin signaling in adipocytes (diabetic condition) WP3635,0.5164015396572211,1.6,1.0573930215896428,['RPS6'],0.9999321719694557,0,0,1
124,Insulin signaling in adipocytes (normal condition) WP3634,0.5164015396572211,1.6,1.0573930215896428,['RPS6'],0.9999321719694557,0,0,1
125,Iron metabolism in placenta WP2007,0.5164015396572211,1.6,1.0573930215896428,['FTH1'],0.9999321719694557,0,0,1
126,Matrix Metalloproteinases WP129,0.5164015396572211,1.6,1.0573930215896428,['MMP16'],0.9999321719694557,0,0,1
127,miR-509-3p alteration of YAP1/ECM axis WP3967,0.5164015396572211,1.6,1.0573930215896428,['COL5A1'],0.9999321719694557,0,0,1
128,Nanoparticle triggered autophagic cell death WP2509,0.5164015396572211,1.6,1.0573930215896428,['MAP1LC3A'],0.9999321719694557,0,0,1
129,Overview of interferons-mediated signaling pathway WP4558,0.5164015396572211,1.6,1.0573930215896428,['IFNGR2'],0.9999321719694557,0,0,1
130,Pathways of nucleic acid metabolism and innate immune sensing WP4705,0.5164015396572211,1.6,1.0573930215896428,['IRF3'],0.9999321719694557,0,0,1
131,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.5164015396572211,1.6,1.0573930215896428,['ANAPC11'],0.9999321719694557,0,0,1
132,Nucleotide Excision Repair WP4753,0.5201000457467183,1.1293666892044174,0.738305505120702,"['POLE4', 'POLD2', 'GTF2H5']",0.9999321719694557,0,0,3
133,Unfolded protein response WP4925,0.5413216930029762,1.1634972170686457,0.7140865856956523,"['DDIT3', 'EIF2S1']",0.9999321719694557,0,0,2
134,Complement system WP2806,0.5413216930029762,1.1634972170686457,0.7140865856956523,"['RPS19', 'CD59']",0.9999321719694557,0,0,2
135,DNA Replication WP466,0.5413216930029762,1.1634972170686457,0.7140865856956523,"['POLD2', 'UBA52']",0.9999321719694557,0,0,2
136,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.5413216930029762,1.1634972170686457,0.7140865856956523,"['RAB4B', 'RABAC1']",0.9999321719694557,0,0,2
137,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.5413216930029762,1.1634972170686457,0.7140865856956523,"['HSP90AA1', 'BAX']",0.9999321719694557,0,0,2
138,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.5449301384138145,1.0178550589333644,0.6179374437677839,"['YWHAE', 'SST', 'ATP1A3', 'SSTR2', 'NGF', 'GAPDH', 'SLC25A4']",0.9999321719694557,0,0,7
139,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.5545330398270782,1.066411238825032,0.6287868740367258,"['BEX3', 'RNF7', 'SQSTM1']",0.9999321719694557,0,0,3
140,Exercise-induced Circadian Regulation WP410,0.5545330398270782,1.066411238825032,0.6287868740367258,"['DAZAP2', 'SUMO1', 'GSTP1']",0.9999321719694557,0,0,3
141,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.5545330398270782,1.066411238825032,0.6287868740367258,"['STMN1', 'BAX', 'ANGPTL1']",0.9999321719694557,0,0,3
142,Serotonin and anxiety-related events WP3944,0.5818357858612606,1.2797452229299362,0.6930678143449241,['CRH'],0.9999321719694557,0,0,1
143,BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation WP3876,0.5818357858612606,1.2797452229299362,0.6930678143449241,['SST'],0.9999321719694557,0,0,1
144,Thiamine metabolic pathways WP4297,0.5818357858612606,1.2797452229299362,0.6930678143449241,['BCKDK'],0.9999321719694557,0,0,1
145,Ebstein-Barr virus LMP1 signaling WP262,0.5818357858612606,1.2797452229299362,0.6930678143449241,['HSP90AA1'],0.9999321719694557,0,0,1
146,Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome WP4320,0.5818357858612606,1.2797452229299362,0.6930678143449241,['H3F3B'],0.9999321719694557,0,0,1
147,FGF23 signaling in hypophosphatemic rickets and related disorders WP4790,0.5818357858612606,1.2797452229299362,0.6930678143449241,['ENPP1'],0.9999321719694557,0,0,1
148,Genes targeted by miRNAs in adipocytes WP1992,0.5818357858612606,1.2797452229299362,0.6930678143449241,['TMSB4X'],0.9999321719694557,0,0,1
149,Mitochondrial Gene Expression WP391,0.5818357858612606,1.2797452229299362,0.6930678143449241,['PPRC1'],0.9999321719694557,0,0,1
150,Overview of nanoparticle effects WP3287,0.5818357858612606,1.2797452229299362,0.6930678143449241,['BAX'],0.9999321719694557,0,0,1
151,Oxidative Stress WP408,0.5818357858612606,1.2797452229299362,0.6930678143449241,['TXN2'],0.9999321719694557,0,0,1
152,PI3K/AKT/mTOR - VitD3 signaling WP4141,0.5818357858612606,1.2797452229299362,0.6930678143449241,['LDHA'],0.9999321719694557,0,0,1
153,PPAR-alpha pathway WP2878,0.5818357858612606,1.2797452229299362,0.6930678143449241,['PPARA'],0.9999321719694557,0,0,1
154,SARS coronavirus and innate immunity WP4912,0.5818357858612606,1.2797452229299362,0.6930678143449241,['IRF3'],0.9999321719694557,0,0,1
155,Amyotrophic lateral sclerosis (ALS) WP2447,0.5829535233929303,1.066326530612245,0.5754407829048327,"['TOMM40', 'BAX']",0.9999321719694557,0,0,2
156,Aryl Hydrocarbon Receptor Pathway WP2873,0.5829535233929303,1.066326530612245,0.5754407829048327,"['HSP90AA1', 'BAX']",0.9999321719694557,0,0,2
157,Wnt signaling pathway and pluripotency WP399,0.5874465840484637,1.010082677959266,0.5373336396351056,"['PRKCG', 'WNT2B', 'DVL3']",0.9999321719694557,0,0,3
158,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.5926962161525924,0.984064528821562,0.5147378748886734,"['PRKCG', 'RPS6', 'PDGFC', 'BAX']",0.9999321719694557,0,0,4
159,Nuclear Receptors Meta-Pathway WP2882,0.6159299743454802,0.9468848693654895,0.4588812390868725,"['PSMC5', 'HSP90AA1', 'FTH1', 'GSTP1', 'BLVRB', 'BAX', 'SERPINB9', 'SLC39A7', 'PPARA', 'SQSTM1', 'CES2', 'FTL']",0.9999321719694557,0,0,12
160,Copper homeostasis WP3286,0.6217274408525274,0.984105180533752,0.46769941199650716,"['COX17', 'ATOX1']",0.9999321719694557,0,0,2
161,Energy Metabolism WP1541,0.6217274408525274,0.984105180533752,0.46769941199650716,"['PPRC1', 'PPARA']",0.9999321719694557,0,0,2
162,Genotoxicity pathway WP4286,0.6217274408525274,0.984105180533752,0.46769941199650716,"['RPS27', 'PHLDA3']",0.9999321719694557,0,0,2
163,Glycogen Synthesis and Degradation WP500,0.6217274408525274,0.984105180533752,0.46769941199650716,"['PHKG1', 'CALM2']",0.9999321719694557,0,0,2
164,Pathways in clear cell renal cell carcinoma WP4018,0.6220089577646825,0.9403479701739851,0.4464779542196728,"['LDHA', 'PKM', 'ALDOC', 'GAPDH', 'SQSTM1']",0.9999321719694557,0,0,5
165,Signal Transduction of S1P Receptor WP26,0.6384260360764772,1.0662420382165605,0.47847552859010795,['ASAH1'],0.9999321719694557,0,0,1
166,Alanine and aspartate metabolism WP106,0.6384260360764772,1.0662420382165605,0.47847552859010795,['GOT1'],0.9999321719694557,0,0,1
167,Type I interferon induction and signaling during SARS-CoV-2 infection WP4868,0.6384260360764772,1.0662420382165605,0.47847552859010795,['IRF3'],0.9999321719694557,0,0,1
168,Type II diabetes mellitus WP1584,0.6384260360764772,1.0662420382165605,0.47847552859010795,['SURF1'],0.9999321719694557,0,0,1
169,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.6384260360764772,1.0662420382165605,0.47847552859010795,['BAX'],0.9999321719694557,0,0,1
170,Immune response to tuberculosis WP4197,0.6384260360764772,1.0662420382165605,0.47847552859010795,['IFNGR2'],0.9999321719694557,0,0,1
171,Kynurenine Pathway and links to Cellular Senescence WP5044,0.6384260360764772,1.0662420382165605,0.47847552859010795,['EIF2AK1'],0.9999321719694557,0,0,1
172,Nuclear Receptors in Lipid Metabolism and Toxicity WP299,0.6384260360764772,1.0662420382165605,0.47847552859010795,['PPARA'],0.9999321719694557,0,0,1
173,Prostaglandin Synthesis and Regulation WP98,0.6384260360764772,1.0662420382165605,0.47847552859010795,['S100A6'],0.9999321719694557,0,0,1
174,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.6384260360764772,1.0662420382165605,0.47847552859010795,['BAX'],0.9999321719694557,0,0,1
175,Apoptosis WP254,0.6484128264599441,0.9135194307608101,0.39576192884344685,"['IRF3', 'CYCS', 'BAX']",0.9999321719694557,0,0,3
176,Wnt Signaling Pathway WP363,0.6576544184791332,0.9136297376093294,0.3828800085839363,"['PRKCG', 'DVL3']",0.9999321719694557,0,0,2
177,G13 Signaling Pathway WP524,0.6576544184791332,0.9136297376093294,0.3828800085839363,"['ARHGDIG', 'CALM2']",0.9999321719694557,0,0,2
178,One-carbon metabolism and related pathways WP3940,0.6576544184791332,0.9136297376093294,0.3828800085839363,"['GPX4', 'GSS']",0.9999321719694557,0,0,2
179,Serotonin and anxiety WP3947,0.6873663130486641,0.913739763421292,0.3425500012467685,['CRH'],0.9999321719694557,0,0,1
180,Sleep regulation WP3591,0.6873663130486641,0.913739763421292,0.3425500012467685,['CRH'],0.9999321719694557,0,0,1
181,Airway smooth muscle cell contraction WP4962,0.6873663130486641,0.913739763421292,0.3425500012467685,['CALM2'],0.9999321719694557,0,0,1
182,SREBF and miR33 in cholesterol and lipid homeostasis WP2011,0.6873663130486641,0.913739763421292,0.3425500012467685,['PPARA'],0.9999321719694557,0,0,1
183,Striated Muscle Contraction Pathway WP383,0.6873663130486641,0.913739763421292,0.3425500012467685,['DMD'],0.9999321719694557,0,0,1
184,T-Cell Receptor and Co-stimulatory Signaling WP2583,0.6873663130486641,0.913739763421292,0.3425500012467685,['CALM2'],0.9999321719694557,0,0,1
185,Cell migration and invasion through p75NTR WP4561,0.6873663130486641,0.913739763421292,0.3425500012467685,['CDH11'],0.9999321719694557,0,0,1
186,Constitutive Androstane Receptor Pathway WP2875,0.6873663130486641,0.913739763421292,0.3425500012467685,['HSP90AA1'],0.9999321719694557,0,0,1
187,Follicle Stimulating Hormone (FSH) signaling pathway WP2035,0.6873663130486641,0.913739763421292,0.3425500012467685,['RPS6'],0.9999321719694557,0,0,1
188,Melatonin metabolism and effects WP3298,0.6873663130486641,0.913739763421292,0.3425500012467685,['CALM2'],0.9999321719694557,0,0,1
189,MTHFR deficiency WP4288,0.6873663130486641,0.913739763421292,0.3425500012467685,['CYCS'],0.9999321719694557,0,0,1
190,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.6873663130486641,0.913739763421292,0.3425500012467685,['GSTP1'],0.9999321719694557,0,0,1
191,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.6873663130486641,0.913739763421292,0.3425500012467685,['BAX'],0.9999321719694557,0,0,1
192,Common Pathways Underlying Drug Addiction WP2636,0.6907946446329817,0.8525510204081632,0.31536943718897253,"['PRKCG', 'CALM2']",0.9999321719694557,0,0,2
193,Development of ureteric collection system WP5053,0.6907946446329817,0.8525510204081632,0.31536943718897253,"['ROBO2', 'GDF11']",0.9999321719694557,0,0,2
194,Non-small cell lung cancer WP4255,0.7026859141960374,0.8337497917707812,0.29418466725870207,"['PRKCG', 'CYCS', 'BAX']",0.9999321719694557,0,0,3
195,Adipogenesis WP236,0.7088611462467268,0.8406900734550846,0.28927776880323147,"['CELF1', 'DDIT3', 'MIF', 'PPARA', 'ZMPSTE24']",0.9999321719694557,0,0,5
196,Breast cancer pathway WP4262,0.7088611462467268,0.8406900734550846,0.28927776880323147,"['WNT2B', 'KIT', 'DVL3', 'BAX', 'FGF1']",0.9999321719694557,0,0,5
197,DNA damage response (only ATM dependent) WP710,0.7156181276085365,0.8245194290900091,0.27589128823533665,"['WNT2B', 'BCL6', 'DVL3', 'BAX']",0.9999321719694557,0,0,4
198,MAPK Signaling Pathway WP382,0.7164699555309293,0.8576614994525442,0.28596060934754114,"['PRKCG', 'DUSP4', 'MAP4K2', 'DUSP3', 'DDIT3', 'STMN1', 'FGF1', 'RASGRP2', 'NGF']",0.9999321719694557,0,0,9
199,Kit receptor signaling pathway WP304,0.7212440450447037,0.7991071428571429,0.2611304082855384,"['RPS6', 'KIT']",0.9999321719694557,0,0,2
200,Regulatory circuits of the STAT3 signaling pathway WP4538,0.7212440450447037,0.7991071428571429,0.2611304082855384,"['IFNGR2', 'STMN1']",0.9999321719694557,0,0,2
201,TNF-alpha signaling pathway WP231,0.7273198385639583,0.7988505747126436,0.25434519983656645,"['MAP4K2', 'HSP90AA1', 'BAX']",0.9999321719694557,0,0,3
202,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.7296896131438435,0.7993630573248408,0.25190809460401176,['RPS6'],0.9999321719694557,0,0,1
203,Toll-like Receptor Signaling related to MyD88 WP3858,0.7296896131438435,0.7993630573248408,0.25190809460401176,['IRF3'],0.9999321719694557,0,0,1
204,Trans-sulfuration and one-carbon metabolism WP2525,0.7296896131438435,0.7993630573248408,0.25190809460401176,['GSS'],0.9999321719694557,0,0,1
205,GDNF/RET signaling axis WP4830,0.7296896131438435,0.7993630573248408,0.25190809460401176,['ROBO2'],0.9999321719694557,0,0,1
206,Metabolism of Spingolipids in ER and Golgi apparatus WP4142,0.7296896131438435,0.7993630573248408,0.25190809460401176,['B3GALT2'],0.9999321719694557,0,0,1
207,Nanoparticle-mediated activation of receptor signaling WP2643,0.7296896131438435,0.7993630573248408,0.25190809460401176,['TLN1'],0.9999321719694557,0,0,1
208,"Oligodendrocyte specification and differentiation, leading to myelin components for CNS WP4304",0.7296896131438435,0.7993630573248408,0.25190809460401176,['OMG'],0.9999321719694557,0,0,1
209,Physiological and pathological hypertrophy of the heart WP1528,0.7296896131438435,0.7993630573248408,0.25190809460401176,['CALM2'],0.9999321719694557,0,0,1
210,Glucocorticoid Receptor Pathway WP2880,0.7491235423586204,0.7519507803121248,0.2172020100561266,"['HSP90AA1', 'SERPINB9']",0.9999321719694557,0,0,2
211,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.7491235423586204,0.7519507803121248,0.2172020100561266,"['WNT2B', 'DVL3']",0.9999321719694557,0,0,2
212,Rett syndrome causing genes WP4312,0.7491235423586204,0.7519507803121248,0.2172020100561266,"['IMPDH2', 'GPS2']",0.9999321719694557,0,0,2
213,Apoptosis Modulation and Signaling WP1772,0.7503247790123944,0.7667432950191571,0.22024634251285924,"['ENDOG', 'CYCS', 'BAX']",0.9999321719694557,0,0,3
214,Wnt signaling WP428,0.7503247790123944,0.7667432950191571,0.22024634251285924,"['PRKCG', 'WNT2B', 'DVL3']",0.9999321719694557,0,0,3
215,Regulation of toll-like receptor signaling pathway WP1449,0.7564108011534709,0.7742385491746105,0.21614468879525767,"['OTUD5', 'IRF3', 'SQSTM1', 'RNF41']",0.9999321719694557,0,0,4
216,Sphingolipid Metabolism (general overview) WP4725,0.7662895986253617,0.7104033970276008,0.18910591368397153,['ASAH1'],0.9999321719694557,0,0,1
217,Sphingolipid Metabolism (integrated pathway) WP4726,0.7662895986253617,0.7104033970276008,0.18910591368397153,['ASAH1'],0.9999321719694557,0,0,1
218,TLR4 Signaling and Tolerance WP3851,0.7662895986253617,0.7104033970276008,0.18910591368397153,['IRF3'],0.9999321719694557,0,0,1
219,Canonical and non-canonical Notch signaling WP3845,0.7662895986253617,0.7104033970276008,0.18910591368397153,['MFAP1'],0.9999321719694557,0,0,1
220,Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786,0.7662895986253617,0.7104033970276008,0.18910591368397153,['PPIB'],0.9999321719694557,0,0,1
221,Endothelin Pathways WP2197,0.7662895986253617,0.7104033970276008,0.18910591368397153,['CALM2'],0.9999321719694557,0,0,1
222,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.7662895986253617,0.7104033970276008,0.18910591368397153,['DDIT3'],0.9999321719694557,0,0,1
223,Imatinib and Chronic Myeloid Leukemia WP3640,0.7662895986253617,0.7104033970276008,0.18910591368397153,['KIT'],0.9999321719694557,0,0,1
224,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.7662895986253617,0.7104033970276008,0.18910591368397153,['MAP4K2'],0.9999321719694557,0,0,1
225,miRNA targets in ECM and membrane receptors WP2911,0.7662895986253617,0.7104033970276008,0.18910591368397153,['COL5A1'],0.9999321719694557,0,0,1
226,Oxidative Damage WP3941,0.7662895986253617,0.7104033970276008,0.18910591368397153,['CYCS'],0.9999321719694557,0,0,1
227,Melanoma WP4685,0.7717466697079158,0.7371058060713234,0.19098332628116438,"['KIT', 'BAX', 'CALM2']",0.9999321719694557,0,0,3
228,"GPCRs, Other WP117",0.774570561333092,0.7100340136054422,0.1813757161643,"['SSTR2', 'CELSR2']",0.9999321719694557,0,0,2
229,EGF/EGFR signaling pathway WP437,0.7806897213471906,0.7600146332540699,0.188162516698449,"['NDUFA13', 'STMN1', 'AP2S1', 'NEDD8', 'AP2M1']",0.9999321719694557,0,0,5
230,ESC Pluripotency Pathways WP3931,0.7916411353436098,0.709663686675181,0.16581086363998276,"['WNT2B', 'DVL3', 'FGF1']",0.9999321719694557,0,0,3
231,MECP2 and Associated Rett Syndrome WP3584,0.7916411353436098,0.709663686675181,0.16581086363998276,"['BCL6', 'SST', 'RPS6']",0.9999321719694557,0,0,3
232,Metapathway biotransformation Phase I and II WP702,0.7925314066051237,0.7297040555352576,0.1696730813506563,"['GPX4', 'GSTO1', 'GSTP1', 'GSS']",0.9999321719694557,0,0,4
233,BDNF-TrkB Signaling WP3676,0.7979393704801919,0.6392356687898089,0.144289976331922,['TRPC3'],0.9999321719694557,0,0,1
234,Fas ligand pathway and stress induction of heat shock proteins WP314,0.7979393704801919,0.6392356687898089,0.144289976331922,['CYCS'],0.9999321719694557,0,0,1
235,Fatty acid beta-oxidation WP143,0.7979393704801919,0.6392356687898089,0.144289976331922,['ECI1'],0.9999321719694557,0,0,1
236,Glycosylation and related congenital defects WP4521,0.7979393704801919,0.6392356687898089,0.144289976331922,['DPM2'],0.9999321719694557,0,0,1
237,Host-pathogen interaction of human coronaviruses - interferon induction WP4880,0.7979393704801919,0.6392356687898089,0.144289976331922,['IRF3'],0.9999321719694557,0,0,1
238,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.7979393704801919,0.6392356687898089,0.144289976331922,['NELFE'],0.9999321719694557,0,0,1
239,Netrin-UNC5B signaling pathway WP4747,0.7979393704801919,0.6392356687898089,0.144289976331922,['DAPK1'],0.9999321719694557,0,0,1
240,16p11.2 proximal deletion syndrome WP4949,0.8100710781019401,0.6841817186644773,0.144111442544053,"['TMEM219', 'SEZ6L2', 'CCT7']",0.9999321719694557,0,0,3
241,Spinal Cord Injury WP2431,0.8100710781019401,0.6841817186644773,0.144111442544053,"['APEX1', 'OMG', 'MIF']",0.9999321719694557,0,0,3
242,Osteoblast differentiation WP4787,0.8100710781019401,0.6841817186644773,0.144111442544053,"['PRKCG', 'WNT2B', 'FGF1']",0.9999321719694557,0,0,3
243,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.8110886432026708,0.7251775113490863,0.15183616601057506,"['DLG1', 'RPS6', 'NGF', 'SQSTM1', 'EIF2S1']",0.9999321719694557,0,0,5
244,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.8187609100940142,0.6387755102040816,0.12773157390478032,"['CYCS', 'BAX']",0.9999321719694557,0,0,2
245,DNA damage response WP707,0.8187609100940142,0.6387755102040816,0.12773157390478032,"['CYCS', 'BAX']",0.9999321719694557,0,0,2
246,DNA IR-double strand breaks and cellular response via ATM WP3959,0.8187609100940142,0.6387755102040816,0.12773157390478032,"['DCLRE1C', 'BAX']",0.9999321719694557,0,0,2
247,Endometrial cancer WP4155,0.8187609100940142,0.6387755102040816,0.12773157390478032,"['BAX', 'FGF1']",0.9999321719694557,0,0,2
248,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.8187609100940142,0.6387755102040816,0.12773157390478032,"['PRKCG', 'IFI27L2']",0.9999321719694557,0,0,2
249,Fragile X Syndrome  WP4549,0.8249783773251176,0.7089201877934272,0.1363948988092294,"['DUSP3', 'ALDH5A1', 'CLTC', 'AP2S1', 'AP2M1']",0.9999321719694557,0,0,5
250,Tumor suppressor activity of SMARCB1 WP4204,0.8253077151595954,0.5810075275043428,0.11155284923565689,['H3F3B'],0.9999321719694557,0,0,1
251,Fibrin Complement Receptor 3 Signaling Pathway WP4136,0.8253077151595954,0.5810075275043428,0.11155284923565689,['IRF3'],0.9999321719694557,0,0,1
252,Genes controlling nephrogenesis WP4823,0.8253077151595954,0.5810075275043428,0.11155284923565689,['ROBO2'],0.9999321719694557,0,0,1
253,Lung fibrosis WP3624,0.8253077151595954,0.5810075275043428,0.11155284923565689,['FGF1'],0.9999321719694557,0,0,1
254,Pre-implantation embryo WP3527,0.8253077151595954,0.5810075275043428,0.11155284923565689,['DDIT3'],0.9999321719694557,0,0,1
255,22q11.2 copy number variation syndrome WP4657,0.8378088575356988,0.6082361516034985,0.10763669191423163,"['RANBP1', 'MRPL40']",0.9999321719694557,0,0,2
256,miRNA regulation of DNA damage response WP1530,0.8378088575356988,0.6082361516034985,0.10763669191423163,"['CYCS', 'BAX']",0.9999321719694557,0,0,2
257,Prolactin Signaling Pathway WP2037,0.8378088575356988,0.6082361516034985,0.10763669191423163,"['RPS6', 'PPIB']",0.9999321719694557,0,0,2
258,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.8428132193109774,0.6383141762452107,0.1091580512251407,"['PSMC5', 'PSMC1', 'UBA1']",0.9999321719694557,0,0,3
259,Sphingolipid pathway WP1422,0.8489731642086998,0.532484076433121,0.08718239412008963,['ASAH1'],0.9999321719694557,0,0,1
260,Splicing factor NOVA regulated synaptic proteins WP4148,0.8489731642086998,0.532484076433121,0.08718239412008963,['CLASP1'],0.9999321719694557,0,0,1
261,Bladder cancer WP2828,0.8489731642086998,0.532484076433121,0.08718239412008963,['DAPK1'],0.9999321719694557,0,0,1
262,The influence of laminopathies on Wnt signaling WP4844,0.8489731642086998,0.532484076433121,0.08718239412008963,['ZMPSTE24'],0.9999321719694557,0,0,1
263,Cardiac Progenitor Differentiation WP2406,0.8489731642086998,0.532484076433121,0.08718239412008963,['KIT'],0.9999321719694557,0,0,1
264,Type 2 papillary renal cell carcinoma WP4241,0.8489731642086998,0.532484076433121,0.08718239412008963,['ELOB'],0.9999321719694557,0,0,1
265,Folate Metabolism WP176,0.8489731642086998,0.532484076433121,0.08718239412008963,['GPX4'],0.9999321719694557,0,0,1
266,IL-2 signaling pathway WP49,0.8489731642086998,0.532484076433121,0.08718239412008963,['RPS6'],0.9999321719694557,0,0,1
267,Integrated Cancer Pathway WP1971,0.8489731642086998,0.532484076433121,0.08718239412008963,['BAX'],0.9999321719694557,0,0,1
268,Neovascularisation processes WP4331,0.8489731642086998,0.532484076433121,0.08718239412008963,['KIT'],0.9999321719694557,0,0,1
269,Peptide GPCRs WP24,0.8489731642086998,0.532484076433121,0.08718239412008963,['SSTR2'],0.9999321719694557,0,0,1
270,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.8489731642086998,0.532484076433121,0.08718239412008963,['IRF3'],0.9999321719694557,0,0,1
271,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.8550266408155432,0.5804730983302412,0.09091523589067356,"['APEX1', 'RPS6']",0.9999321719694557,0,0,2
272,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.8550266408155432,0.5804730983302412,0.09091523589067356,"['WNT2B', 'DVL3']",0.9999321719694557,0,0,2
273,Vitamin D-sensitive calcium signaling in depression WP4698,0.8694361607242503,0.49142577168054874,0.06875556083418043,['GPX4'],0.9999321719694557,0,0,1
274,Interleukin-11 Signaling Pathway WP2332,0.8694361607242503,0.49142577168054874,0.06875556083418043,['RPS6'],0.9999321719694557,0,0,1
275,Nuclear receptors WP170,0.8694361607242503,0.49142577168054874,0.06875556083418043,['PPARA'],0.9999321719694557,0,0,1
276,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.8705602646243433,0.5551242236024845,0.0769503718758815,"['RPS6', 'ZNF516']",0.9999321719694557,0,0,2
277,Aryl Hydrocarbon Receptor Netpath WP2586,0.8871295882748899,0.4562329390354868,0.054640377555050204,['HSP90AA1'],0.9999321719694557,0,0,1
278,IL-5 signaling pathway WP127,0.8871295882748899,0.4562329390354868,0.054640377555050204,['RPS6'],0.9999321719694557,0,0,1
279,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.8871295882748899,0.4562329390354868,0.054640377555050204,['PRKCG'],0.9999321719694557,0,0,1
280,Prader-Willi and Angelman Syndrome WP3998,0.8871295882748899,0.4562329390354868,0.054640377555050204,['NGF'],0.9999321719694557,0,0,1
281,Senescence and Autophagy in Cancer WP615,0.8938721108364427,0.5627676357899482,0.06313834556972305,"['GABARAPL1', 'MAP1LC3A', 'SQSTM1']",0.9999321719694557,0,0,3
282,Pathways Regulating Hippo Signaling WP4540,0.8938721108364427,0.5627676357899482,0.06313834556972305,"['PRKCG', 'KIT', 'CDH11']",0.9999321719694557,0,0,3
283,Joubert Syndrome WP4656,0.8971281119526247,0.5105102040816326,0.055419254282923366,"['CEP120', 'DVL3']",0.9999321719694557,0,0,2
284,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.8971281119526247,0.5105102040816326,0.055419254282923366,"['EIF2B5', 'CALM2']",0.9999321719694557,0,0,2
285,Retinoblastoma gene in cancer WP2446,0.8971281119526247,0.5105102040816326,0.055419254282923366,"['H2AFZ', 'STMN1']",0.9999321719694557,0,0,2
286,Myometrial relaxation and contraction pathways WP289,0.8980960755657015,0.6369230769230769,0.06845536369418564,"['PRKCG', 'YWHAE', 'GSTO1', 'RGS16', 'CRH', 'CALM2']",0.9999321719694557,0,0,6
287,Disruption of postsynaptic signaling by CNV WP4875,0.9024278809000176,0.4257324840764331,0.0437084650676215,['DLG1'],0.9999321719694557,0,0,1
288,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.9024278809000176,0.4257324840764331,0.0437084650676215,['MAP1LC3A'],0.9999321719694557,0,0,1
289,Pathogenic Escherichia coli infection WP2272,0.9024278809000176,0.4257324840764331,0.0437084650676215,['ARPC3'],0.9999321719694557,0,0,1
290,Photodynamic therapy-induced unfolded protein response WP3613,0.9024278809000176,0.4257324840764331,0.0437084650676215,['DDIT3'],0.9999321719694557,0,0,1
291,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.9024278809000176,0.4257324840764331,0.0437084650676215,['CALM2'],0.9999321719694557,0,0,1
292,Corticotropin-releasing hormone signaling pathway WP2355,0.9084206386839717,0.49077708006279436,0.04713803389377401,"['HSP90AA1', 'CRH']",0.9999321719694557,0,0,2
293,Endochondral Ossification with Skeletal Dysplasias WP4808,0.9084206386839717,0.49077708006279436,0.04713803389377401,"['ENPP1', 'CALM2']",0.9999321719694557,0,0,2
294,Endochondral Ossification WP474,0.9084206386839717,0.49077708006279436,0.04713803389377401,"['ENPP1', 'CALM2']",0.9999321719694557,0,0,2
295,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.915654906712986,0.39904458598726117,0.03516210287726026,['ZMPSTE24'],0.9999321719694557,0,0,1
296,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.915654906712986,0.39904458598726117,0.03516210287726026,['BANF1'],0.9999321719694557,0,0,1
297,IL-6 signaling pathway WP364,0.915654906712986,0.39904458598726117,0.03516210287726026,['VIP'],0.9999321719694557,0,0,1
298,p38 MAPK Signaling Pathway WP400,0.915654906712986,0.39904458598726117,0.03516210287726026,['DDIT3'],0.9999321719694557,0,0,1
299,Circadian rhythm related genes WP3594,0.9229976255963528,0.5788615993481551,0.046383379371412146,"['PRKCG', 'CRH', 'PPARA', 'RPS27A', 'UBA52']",0.9999321719694557,0,0,5
300,ATM Signaling Network in Development and Disease  WP3878,0.9270907890850613,0.37549644061446236,0.028426499784191345,['DCLRE1C'],0.9999321719694557,0,0,1
301,Interferon type I signaling pathways WP585,0.9270907890850613,0.37549644061446236,0.028426499784191345,['RPS6'],0.9999321719694557,0,0,1
302,Nephrotic syndrome WP4758,0.9270907890850613,0.37549644061446236,0.028426499784191345,['ZMPSTE24'],0.9999321719694557,0,0,1
303,p53 transcriptional gene network WP4963,0.9270907890850613,0.37549644061446236,0.028426499784191345,['BAX'],0.9999321719694557,0,0,1
304,Leptin signaling pathway WP2034,0.9276090957662476,0.4555393586005831,0.03423144494806492,"['RPS6', 'BAX']",0.9999321719694557,0,0,2
305,Integrated breast cancer pathway WP1984,0.9282585037748033,0.5420906567992599,0.04035595243504302,"['FER', 'ODC1', 'BAX', 'FAU']",0.9999321719694557,0,0,4
306,Vitamin D Receptor Pathway WP2877,0.9295241903570647,0.5031256301673724,0.036769652216470806,"['BCL6', 'S100A6', 'CLPTM1L']",0.9999321719694557,0,0,3
307,Hepatitis B infection WP4666,0.9347572204191059,0.530690537084399,0.03580486303982841,"['PRKCG', 'IRF3', 'CYCS', 'BAX']",0.9999321719694557,0,0,4
308,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.9369778084590277,0.35456475583864117,0.02308063410960219,['TMSB4X'],0.9999321719694557,0,0,1
309,Notch Signaling Pathway Netpath WP61,0.9369778084590277,0.35456475583864117,0.02308063410960219,['APH1A'],0.9999321719694557,0,0,1
310,PPAR signaling pathway WP3942,0.9369778084590277,0.35456475583864117,0.02308063410960219,['PPARA'],0.9999321719694557,0,0,1
311,RANKL/RANK signaling pathway WP2018,0.9369778084590277,0.35456475583864117,0.02308063410960219,['SQSTM1'],0.9999321719694557,0,0,1
312,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.9374396533260131,0.6284101998387712,0.04059711689713862,"['HSP90AA1', 'COL5A1', 'PIK3IP1', 'PDGFC', 'KIT', 'RPS6', 'VEGFB', 'FGF1', 'NGF']",0.9999321719694557,0,0,9
313,Calcium Regulation in the Cardiac Cell WP536,0.9408802628092657,0.54858934169279,0.03343070100438431,"['PRKCG', 'YWHAE', 'RGS16', 'ATP1B2', 'CALM2']",0.9999321719694557,0,0,5
314,Endoderm differentiation WP2853,0.9428797741567371,0.4777777777777778,0.02810121543280043,"['DUSP4', 'TCEAL2', 'NME1']",0.9999321719694557,0,0,3
315,B Cell Receptor Signaling Pathway WP23,0.9429557960436588,0.425,0.02496274616481651,"['BCL6', 'CD81']",0.9999321719694557,0,0,2
316,Cardiac Hypertrophic Response WP2795,0.9455255093586944,0.33583640630238015,0.018811678656686658,['CALM2'],0.9999321719694557,0,0,1
317,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.9455255093586944,0.33583640630238015,0.018811678656686658,['RPS6'],0.9999321719694557,0,0,1
318,MET in type 1 papillary renal cell carcinoma WP4205,0.9455255093586944,0.33583640630238015,0.018811678656686658,['RPL11'],0.9999321719694557,0,0,1
319,Phosphodiesterases in neuronal function WP4222,0.9455255093586944,0.33583640630238015,0.018811678656686658,['PDE3A'],0.9999321719694557,0,0,1
320,Ectoderm Differentiation WP2858,0.9461784347785508,0.5092583120204603,0.028174261570723773,"['ARHGDIG', 'DMD', 'MZF1', 'CELSR2']",0.9999321719694557,0,0,4
321,Small cell lung cancer WP4658,0.9494165721674028,0.4112080315997367,0.021344829260816992,"['CYCS', 'BAX']",0.9999321719694557,0,0,2
322,IL-1 signaling pathway WP195,0.952915118377059,0.3189808917197452,0.015384272044613682,['SQSTM1'],0.9999321719694557,0,0,1
323,Thermogenesis WP4321,0.955175673468754,0.3982780612244898,0.018265033537496936,"['RPS6', 'ZNF516']",0.9999321719694557,0,0,2
324,Neural Crest Differentiation WP2064,0.9593033671004374,0.3037306642402184,0.012619376491615316,['DVL3'],0.9999321719694557,0,0,1
325,Androgen receptor signaling pathway WP138,0.9603044519252302,0.38613172541743973,0.01564022977280744,"['SUMO1', 'PARK7']",0.9999321719694557,0,0,2
326,G Protein Signaling Pathways WP35,0.9603044519252302,0.38613172541743973,0.01564022977280744,"['PRKCG', 'CALM2']",0.9999321719694557,0,0,2
327,Regulation of Actin Cytoskeleton WP51,0.9628344492051879,0.4339951236502961,0.016437041686013516,"['TMSB4X', 'BRK1', 'FGF1']",0.9999321719694557,0,0,3
328,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.9648257989883658,0.28986682107701217,0.010379467972636551,['TLN1'],0.9999321719694557,0,0,1
329,TGF-beta Signaling Pathway WP366,0.9689246845784163,0.36392128279883385,0.011488410806258951,"['PARD6A', 'SUMO1']",0.9999321719694557,0,0,2
330,3q29 copy number variation syndrome WP4906,0.9695996306831318,0.27720852949321517,0.008557994075832949,['DLG1'],0.9999321719694557,0,0,1
331,AGE/RAGE pathway WP2324,0.9695996306831318,0.27720852949321517,0.008557994075832949,['CYCS'],0.9999321719694557,0,0,1
332,Toll-like Receptor Signaling Pathway WP75,0.9695996306831318,0.27720852949321517,0.008557994075832949,['IRF3'],0.9999321719694557,0,0,1
333,Oncostatin M Signaling Pathway WP2374,0.9695996306831318,0.27720852949321517,0.008557994075832949,['RPS6'],0.9999321719694557,0,0,1
334,Ras signaling WP4223,0.970340579118208,0.4541468761417611,0.013673525274123405,"['PRKCG', 'KIT', 'RASGRP2', 'CALM2']",0.9999321719694557,0,0,4
335,"GPCRs, Class A Rhodopsin-like WP455",0.9725283834730548,0.35374149659863946,0.009853829434657284,"['SSTR2', 'MCHR1']",0.9999321719694557,0,0,2
336,Hippo-Merlin Signaling Dysregulation WP4541,0.9757271111010929,0.3441119691119691,0.008455633187457167,"['KIT', 'CDH11']",0.9999321719694557,0,0,2
337,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.9772932437031147,0.25492993630573246,0.005855364586832595,['DMD'],0.9999321719694557,0,0,1
338,Head and Neck Squamous Cell Carcinoma WP4674,0.9772932437031147,0.25492993630573246,0.005855364586832595,['RPS6'],0.9999321719694557,0,0,1
339,Insulin Signaling WP481,0.9786207152033293,0.38931894596919225,0.00841362318917179,"['MAP4K2', 'ENPP1', 'STX4']",0.9999321719694557,0,0,3
340,Focal Adhesion WP306,0.9803380087047249,0.4235294117647059,0.008410387740418537,"['PRKCG', 'PDGFC', 'VEGFB', 'TLN1']",0.9999321719694557,0,0,4
341,ErbB signaling pathway WP673,0.9803764766676841,0.24507594316511513,0.004857067288469693,['PRKCG'],0.9999321719694557,0,0,1
342,Cell cycle WP179,0.9810791818071275,0.3263343799058085,0.006233674332273923,"['YWHAE', 'ANAPC11']",0.9999321719694557,0,0,2
343,PI3K-Akt signaling pathway WP4172,0.981462415370315,0.4986658204843432,0.009330814946184476,"['HSP90AA1', 'PDGFC', 'KIT', 'RPS6', 'VEGFB', 'FGF1', 'NGF']",0.9999321719694557,0,0,7
344,Gastrin signaling pathway WP4659,0.983306832120821,0.3181122448979592,0.005355123501083786,"['RPS6', 'KIT']",0.9999321719694557,0,0,2
345,DNA IR-damage and cellular response via ATR WP4016,0.9873357391650824,0.2195914781462772,0.002798723281720461,['BCL6'],0.9999321719694557,0,0,1
346,Glioblastoma signaling pathways WP2261,0.9873357391650824,0.2195914781462772,0.002798723281720461,['PRKCG'],0.9999321719694557,0,0,1
347,Pancreatic adenocarcinoma pathway WP4263,0.9890563890920513,0.21222929936305732,0.0023353569300791047,['BAX'],0.9999321719694557,0,0,1
348,Integrin-mediated Cell Adhesion WP185,0.9918286494169775,0.19888535031847135,0.0016318382015417913,['TLN1'],0.9999321719694557,0,0,1
349,Genes related to primary cilium development (based on CRISPR) WP4536,0.994728560671077,0.18172884440400364,0.0009605064333859225,['CEP120'],0.9999321719694557,0,0,1
350,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.9965998172865088,0.16728126047603084,0.0005697560373353545,['MAP4K2'],0.9999321719694557,0,0,1
351,Mesodermal commitment pathway WP2857,0.9970622363621888,0.1629593336599706,0.00047944059175999867,['RPL38'],0.9999321719694557,0,0,1
352,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.9978069990065777,0.15494795712288334,0.0003401741615179923,['WNT2B'],0.9999321719694557,0,0,1
353,Chemokine signaling pathway WP3929,0.9987779053892022,0.1410615711252654,0.00017249601056722134,['RASGRP2'],0.9999321719694557,0,0,1
354,Ciliopathies WP4803,0.9999321719694557,0.09726604605585497,6.597588096030967e-06,['CEP120'],0.9999321719694557,0,0,1
